Four leading geneticists formed Genomics plc in 2014 to combine cutting-edge science with commercial delivery. We have built the world's largest genomic database, which continues to expand in size and diversity every week. Our algorithms overcome the limitations of other methods, and are capable of working at an unprecedented scale of data to tell us how any one of millions of genetic variants affects thousands of molecular, cellular, physiological and disease traits. We use this powerful engine to find new drug targets for serious diseases, and to deliver precision health.